While previous studies have examined the association of TIMP3 with prognosis and pathogenesis in cancer [28,29], including some links to immune processes, our work provides novel insights by integrating multi-omics data and single-cell transcriptomic analyses to specifically characterize the expression patterns of TIMP3 across diverse immune cell types within the tumor microenvironment. The gene discussed is TIMP3; the disease is neoplasm.